Photo: The AI-powered ClarityDX test uses blood-based biomarkers to improve prostate cancer detection and reduce health-care costs. (Commercialization and adoption project funded through the Canadian Genomics Strategy)
We are living through profound technological change. While breakthroughs in artificial intelligence (AI) large language models are making headlines, an equally transformative—and closely linked—revolution is unfolding in the life sciences. The digitization of biology through genomics is fundamentally altering the foundations of entire sectors, from health care to agriculture, to natural resources, to the blue economy.
Unlocking the full potential of the biorevolution driven by genomics and the rise of AI requires the mutual reinforcement of these transformative general-purpose technologies.
Read our new white paper: Genomics, the Digitization of Biology, and Canada’s AI Opportunity
AFN resolution on genomic data sovereignty
October 3, 2025
Genome Canada 2024-25 Annual Report
July 30, 2025